Xencor Inc (NASDAQ:XNCR), a biopharmaceutical company with a market capitalization of $1.14 billion, disclosed on Thursday ...
Total net revenues for the second quarter of fiscal 2025 increased 2% to $15.5 million, compared with $15.2 million in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback